EGF Theramed Health Corp.

CNSX: TMED


Canadian symbol: TMED.CN
US symbol: EVAHF

Currency in CAD

Valuation Measures

Market Cap (intraday) 51.75M
Enterprise Value 32.3M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 7N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.39
52-Week Change 3-91.23%
S&P500 52-Week Change 343.61%
52 Week High 32.0000
52 Week Low 30.0550
50-Day Moving Average 30.1220
200-Day Moving Average 30.1454

Share Statistics

Avg Vol (3 month) 362.84k
Avg Vol (10 day) 335.27k
Shares Outstanding 518.45M
Implied Shares Outstanding 6N/A
Float 21.38M
% Held by Insiders 16.64%
% Held by Institutions 10.00%
Shares Short (Apr. 14, 2021) 45.48k
Short Ratio (Apr. 14, 2021) 40.08
Short % of Float (Apr. 14, 2021) 4N/A
Short % of Shares Outstanding (Apr. 14, 2021) 40.03%
Shares Short (prior month Mar. 14, 2021) 459.25k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:100
Last Split Date 3Oct. 23, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun. 29, 2020
Most Recent Quarter (mrq)Dec. 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-66.73%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-577.01k
EBITDA N/A
Net Income Avi to Common (ttm)-19.58M
Diluted EPS (ttm)-1.6350
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)34.21k
Total Cash Per Share (mrq)0
Total Debt (mrq)1.57M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.09
Book Value Per Share (mrq)-0.05

Cash Flow Statement

Operating Cash Flow (ttm)-1.66M
Levered Free Cash Flow (ttm)-186.89k

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Psychedelics News and Psilocybin Investing

Real-time news from hundreds of sources. Never miss the news that matters the most.




Company News Date

Analysts data is not available


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
6.64%% of Shares Held by All Insider
0.00%% of Shares Held by Institutions
0.00%% of Float Held by Institutions
0Number of Institutions Holding Shares
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by EGF Theramed Health Corp.


EGF Theramed Health Announces MOU with Greenfield Global Projects and Joint Venture Partner Green Parrot

VANCOUVER, BC / ACCESSWIRE / July 9, 2020 / EGF THERAMED HEALTH CORP. (TMED.CN)(OTC PINK:EVAHF)(AUHP.F) (the "Company") announces that Global Green Parrot Laboratories Inc. ("GGP") has entered into a Memorandum of Understanding ("MOU") with Greenfield Global Projects Inc. ("Greenfield"). Greenfield is a private company with extensive ca... Read More...

EGF Theramed Health Amends Financing

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICESVANCOUVER, BC / ACCESSWIRE / June 10, 2020 / EGF THERAMED HEALTH CORP. (TMED.CN)(EVAHF)(AUHP.F) (the "Company") reports that further to the Company's press release dated May 22, 2020, the Company has amended the terms of the financing to raise up to C... Read More...

EGF Theramed Health Announces Early Stage Due Diligence On Cash-Generating Psilocybin Assets/Clinics

VANCOUVER, BC / ACCESSWIRE / May 27, 2020 / EGF THERAMED HEALTH CORP. (TMED.CN)(OTC PINK:EVAHF)(AUHP.F)(the "Company") announces that it has commenced due diligence and research into additional acquisition opportunities that complement its current work in the health sciences sector. Specifically, the Company is further investigating the p... Read More...

EGF Theramed Health Closes Joint Venture with Acquisition of 40% Interest in Biosynthesis and Wellness Company, Green Parrot Labs

VANCOUVER, BC / ACCESSWIRE / May 26, 2020 / EGF THERAMED HEALTH CORP. (TMED.CN)(OTC PINK:EVAHF)(AUHP.F) (the "Company") is pleased to announce that it closed on the joint venture transaction with Green Parrot Labs Corp. ("Green Parrot"), previously announced on May 22, 2020.Pursuant to the announced Joint Venture and Share Purchase Agreem... Read More...

EGF Theramed Health Comments Further on Recent Market Activity at the Request of OTC Markets

VANCOUVER, BC / ACCESSWIRE / May 25, 2020 / EGF THERAMED HEALTH CORP. (TMED.CN)(EVAHF)(AUHP.F) (the "Company").Further to the Company's press releases dated May 19, 2020 and May 22, 2020 (the "Prior News Releases"), the Company has been requested by OTC Markets Group to comment further on recent promotional activity. The Company is aware ... Read More...

EGF Theramed Health Announces $2 Million Financing and Joint Venture with Acquisition of 40% Interest in Biosynthesis and Wellness Company, Green Parrot Labs

VANCOUVER, BC / ACCESSWIRE / May 22, 2020 / EGF THERAMED HEALTH CORP. (TMED.CN) (OTC PINK:EVAHF) (AUHP.F) (the "Company").The Company is pleased to announce that it has entered into a definitive Joint Venture and Share Purchase Agreement with Green Parrot Labs Corp. ("Green Parrot") and its shareholders, pursuant to which the Company will... Read More...

EGF Theramed Health Closes Joint Venture With Acquisition Of 30% Interest Of Biosynthesis Company, Pharmadelic Labs

VANCOUVER, BC / ACCESSWIRE / May 6, 2020 / EGF THERAMED HEALTH CORP. (TMED.CN)(EVAHF) (the "Company") is pleased to announce that it closed on the joint venture transaction with Pharmadelic Labs Corp. ("Pharmadelic Labs"), previously announced on May 4, 2020.Pursuant to the announced Joint Venture and Share Purchase Agreement (the "Agreem... Read More...

EGF Theramed Health Corp. Announces $1.7m Non-brokered Private Placement and Early Stage Due Diligence on Psilocybin Assets

Vancouver, British Columbia--(Newsfile Corp. - April 13, 2020) - ย EGF Theramed Health Corp. (CSE: TMED) (OTCQB: EVAHF) (the "Company") is pleased to announce a non-brokered private placement (the "Offering") financing of up to 3,400,000 million units (the "Units") of the Company at a price of $0.50 per Unit for gross proceeds of $1,700,00... Read More...

Theramed Provides Operational Update for Nevada Lab

VANCOUVER, BC / ACCESSWIRE / September 17, 2019 / THERAMED HEALTH CORP. (TMED.CN)(EVAHF) (the "Company") is pleased to announce that it has received final sign off on its operational permits for its Nevada hemp extraction lab and has completed commissioning of its Vitalis CO2 hemp extraction system.While the permitting process has been un... Read More...

Theramed Announces Launch of Development Initiative for Asia Pacific Region to be Named EGF-Theramed Health

VANCOUVER, BC / ACCESSWIRE / September 5, 2019 / Theramed Health Corporation (CSE:TMED, OTCQB:EVAHF) (the โ€œCompanyโ€) is pleased to announce the signing of a proposed joint venture agreement with an agent to develop the Asia Pacific market from the Hong Kong SAR (Special Administration Region) for the Companyโ€™s licensed cardio-metabolic he... Read More...

Theramed Scientific Advisor and Resident Cannabinologist to Co-Host Panels at Major Extraction Conference

VANCOUVER, BC / ACCESSWIRE / May 28, 2019 / THERAMED HEALTH CORP. (CSE: TMED, OTCQB: EVAHF) (the "Company") is pleased to have one of their scientific advisors co-hosting various panels in one of the leading international extraction and analytical testing conferences.THERAMED'S Chief Science Advisor, Dr. Ricardo E Rivera-Acevedo will be a... Read More...
Coming Soon.
SymbolExchangePriceChangeAs of
TMED.CD
Canadian Securities Exchange - CSE Listed
Canadian Securities Exchange - CSE Listed0.10CAD-5.00%
AUHP.F
Frankfurt Stock Exchange
Frankfurt Stock Exchange0.05EUR+6.00%
AUHP.BE
Berlin Stock Exchange
Berlin Stock Exchange0.07EUR-4.76%
EVAHF.PK
US 'Other OTC' and Grey Market
US 'Other OTC' and Grey Market0.08USD+1.21%
AUHP.MU
Munich Stock Exchange
Munich Stock Exchange0.06EUR+5.47%
AUHP.SG
Stuttgart Stock Exchange
Stuttgart Stock Exchange0.05EUR-5.86%
EVAHF.PQ
OTC MARKETS GROUP L1 AND L2
OTC MARKETS GROUP L1 AND L20.08USD--
AUHP.DEU
German Composite
German Composite0.06EUR+5.45%

Delayed data (1h)


Share this page